Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival - PubMed (original) (raw)

Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival

L Qin et al. J Exp Med. 1994.

Abstract

Indefinite graft survival was obtained with murine cardiac allografts using the combined administration of monoclonal antibodies (mAbs) directed against the receptor ligand pair CD2-CD48. Although each antibody could prolong graft survival when given alone, neither resulted in the indefinite graft survival seen with the combination. Combined mAb administration is associated with inhibition of T cell priming and help and subsequent cytotoxic T lymphocyte generation. This indicates that the interaction between CD2 and its ligand is important for antigen priming and recognition, and combined mAbs may prove to be a useful therapeutic regimen for transplantation.

PubMed Disclaimer

Similar articles

• Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
  Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS. Chavin KD, et al. Transplantation. 1993 Apr;55(4):901-8. doi: 10.1097/00007890-199304000-00040. Transplantation. 1993. PMID: 8097344
• Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
  Chavin KD, Qin L, Woodward JE, Lin J, Bromberg JS. Chavin KD, et al. Transplantation. 1994 Mar 15;57(5):736-40. doi: 10.1097/00007890-199403150-00017. Transplantation. 1994. PMID: 7511258
• Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo.
  Chavin KD, Qin L, Lin J, Woodward J, Baliga P, Kato K, Yagita H, Bromberg JS. Chavin KD, et al. Int Immunol. 1994 May;6(5):701-9. doi: 10.1093/intimm/6.5.701. Int Immunol. 1994. PMID: 7521667
• The biology of human CD2.
  Reinherz EL, Chang HC, Clayton LK, Gardner P, Howard FD, Koyasu S, Jin YJ, Moingeon P, Sayre PH. Reinherz EL, et al. Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:611-25. doi: 10.1101/sqb.1989.054.01.073. Cold Spring Harb Symp Quant Biol. 1989. PMID: 2577023 Review. No abstract available.
• Analysis of the structure and interactions of CD2.
  Davis SJ, Jones EY, Bodian DL, Barclay AN, van der Merwe PA. Davis SJ, et al. Biochem Soc Trans. 1993 Nov;21(4):952-8. doi: 10.1042/bst0210952. Biochem Soc Trans. 1993. PMID: 7907562 Review. No abstract available.

Cited by

• The relationship of C and N stable isotopes to high-latitude moss-associated N2 fixation.
  Stuart JEM, Holland-Moritz H, Jean M, Miller SN, Ponciano JM, McDaniel SF, Mack MC. Stuart JEM, et al. Oecologia. 2021 Sep;197(1):283-295. doi: 10.1007/s00442-021-05005-7. Epub 2021 Jul 28. Oecologia. 2021. PMID: 34319437
• CD58 Immunobiology at a Glance.
  Zhang Y, Liu Q, Yang S, Liao Q. Zhang Y, et al. Front Immunol. 2021 Jun 8;12:705260. doi: 10.3389/fimmu.2021.705260. eCollection 2021. Front Immunol. 2021. PMID: 34168659 Free PMC article. Review.
• Bioinformatics analyses on the immune status of renal transplant patients, a systemic research of renal transplantation.
  Meng M, Zhang W, Tang Q, Yu B, Li T, Rong R, Zhu T, Xu M, Shi Y. Meng M, et al. BMC Med Genomics. 2020 Feb 11;13(1):24. doi: 10.1186/s12920-020-0673-6. BMC Med Genomics. 2020. PMID: 32046717 Free PMC article.
• Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.
  McArdel SL, Brown DR, Sobel RA, Sharpe AH. McArdel SL, et al. J Immunol. 2016 Oct 15;197(8):3038-3048. doi: 10.4049/jimmunol.1600706. Epub 2016 Aug 31. J Immunol. 2016. PMID: 27581174 Free PMC article.
• Roles of CD48 in regulating immunity and tolerance.
  McArdel SL, Terhorst C, Sharpe AH. McArdel SL, et al. Clin Immunol. 2016 Mar;164:10-20. doi: 10.1016/j.clim.2016.01.008. Epub 2016 Jan 18. Clin Immunol. 2016. PMID: 26794910 Free PMC article. Review.

References

1. 1. FASEB J. 1991 Jun;5(9):2292-9 - PubMed
2. 1. J Exp Med. 1991 Nov 1;174(5):957-67 - PubMed
3. 1. Transplantation. 1971 Mar;11(3):298-302 - PubMed
4. 1. J Immunol. 1976 Mar;116(3):868-75 - PubMed
5. 1. J Exp Med. 1979 Jan 1;149(1):273-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal